Kinetic analysis of inhibition of human immunodeficiency virus type-1 reverse transcriptase by calanolide A

Journal of Pharmacology and Experimental Therapeutics

Volumn 279, Issue 2, 1996, Pages 652-661

  Currens, Michael J ^a,b   Mariner, Jennifer M ^a   Mcmahon, James B ^a   Boyd, Michael R ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 ETHOXYMETHYL 5 ETHYL 6 PHENYLTHIO 2 THIOURACIL; CALANOLIDE A; DEOXYRIBONUCLEOSIDE TRIPHOSPHATE; FOSCARNET; NEVIRAPINE; NSC 313410; NSC 641530; NSC 648400; NSC 650886; RNA DIRECTED DNA POLYMERASE INHIBITOR; THIOURACIL DERIVATIVE; THYMIDINE TRIPHOSPHATE; UNCLASSIFIED DRUG; ZIDOVUDINE;

ANTIVIRAL ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVE SITE; ENZYME INHIBITION; HUMAN IMMUNODEFICIENCY VIRUS 1; INHIBITION KINETICS; NONHUMAN; PRIORITY JOURNAL;

ANTI-HIV AGENTS; BINDING SITES; COUMARINS; HIV-1 REVERSE TRANSCRIPTASE; HUMANS; KINETICS; PYRANOCOUMARINS; REVERSE TRANSCRIPTASE INHIBITORS;

EID: 0030434064     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. BABA, M., DECLERCQ, E., TANAKA, H., UBASAWA, M., TAKASHIMA, H., SEKIYA, K., NITTA, I., UMEZU, K., NAKASHIMA, H. AND MORI, S: Potent and selective inhibition of human immunodeficiency virus type 1 (HIV-1) by 5-ethyl-6-phenylthiouracil derivatives through their interaction with the HIV-1 reverse transcriptase. Proc. Natl. Acad. Sci U.S.A. 88: 2356-2360, 1991a.
2. BABA, M., DECLERCQ, E., TANAKA, H., UBASAWA, M., TAKASHIMA, H., SEKIYA, K., NITTA, I., UMEZU, K., WALKER, R. T. AND MORI, S: Highly potent and selective inhibition of human immunodeficiency virus type 1 by a novel series of 6-substituted acyclouridine derivatives. Mol. Pharmacol. 39: 805-810, 1991b.
3. BALZARINI, J., KARLSSON, A., VANDAMME, A. M., PEREZ-PEREZ, M. J., ZHANG, H., VRANG, L., OBERG, B., BACKBRO, K., UNGE, T. AND SAN-FELIX, A.: Human immunodeficiency virus type 1 (HIV-1) strains selected for resistance against the HIV-1-specific [2′,5′-bis-O-(tert-butyldimethylsilyl)-3′-spiro-5″- (4″-amino-1′,2″-oxathiole-2″,2″-dioxide)]-beta-D- pentofuranosyl (TSAO) nucleoside analogues retain sensitivity to HIV-1-specific nonnucleoside inhibitors. Proc. Natl. Acad. Sci. U.S.A. 90: 6952-6956, 1993.
4. BOYER, P. L., CURRENS, M. J., MCMAHON, J. B., BOYD, M. R. AND HUGHES, S. H.: Analysis of nonnucleoside drug-resistant variants of human immunodeficiency virus type 1 reverse transcriptase. J. Virol. 67: 2412-2420, 1993.
5. BOYER, P. L., DING, J., ARNOLD, E. AND HUGHES, S. H.: Subunit specificity of mutations that confer resistance to nonnucleoside inhibitors in human immunodeficiency virus type 1 reverse transcriptase. Antimicrob. Agents Chemother. 38: 1909-1914, 1994.
6. BUCKHEIT, R. W., JR, FLIAKAS-BOLTZ, V., DECKER, W. D., ROBERSON, J. L., STUP, T. L., PYLE, C. A., WHITE, E. L., MCMAHON, J. B., CURRENS, M. J., BOYD, M. R. AND BADER, J. P.: Comparative anti-HIV evaluation of diverse HIV-1-specific reverse transcriptase inhibitor-resistant virus isolates demonstrates the existence of distinct phenotypic subgroups. Antiviral Res. 26: 117-132, 1995.
7. CURRENS, M. J., GULAKOWSKI, R. J., MARINER, J. M., MORAN, R. A., BUCKHEIT, R. W., JR., GUSTAFSON, K. R., MCMAHON, J. B. AND BOYD, M. R.: Antiviral activity and mechanism of action of calanolide A against the human immunodeficiency virus type-1. J. Pharmacol. Exp. Ther. 279: 645-651, 1996.
8. DEBYSER, Z., PAUWELS, R., BABA, M., DESMYTER, J. AND DECLERCQ, E: Common features in the interaction of tetrahydroimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-one and-thione and 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives with the human immunodeficiency virus type 1 reverse transcriptase. Mol. Pharmacol. 41: 963-968, 1992a.
9. DEBYSER, Z., VANDAMME, A. M., PAUWELS, R., BABA, M., DESMYTER, J. AND DE CLERCQ, E.: Kinetics of inhibition of endogenous human immunodeficiency virus type 1 reverse transcription by 2′,3′-dideoxynucleoside 5′-triphosphate, tetrahydroimidazo-[4,5,1-jk][1,4]-benzodiazepin-2(1H)-thione, and 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives. J Biol. Chem. 267: 11769-11776, 1992b.
10. DECLERCQ, E: HIV inhibitors targeted at the reverse transcriptase. Aids Res. Hum. Retroviruses 8: 119-134, 1992.
11. DECLERCQ, E: HIV resistance to reverse transcriptase inhibitors. Biochem. Pharmacol. 47: 155-169, 1994.
12. DUEWEKE, T. J., KEZDY, F. J., WASZAK, G. A., DEIBEL, M., JR. AND TARPLEY, W. G.: The binding of a novel bisheteroarylpiperazine mediates inhibition of human immunodeficiency virus type 1 reverse transcriptase. J Biol. Chem. 267: 27-30, 1992.
13. GOLDMAN, M. E., NUNBERG, J. H., O'BRIEN, J. A., QUINTERO, J. C., SCHLEIF, W. A., FREUND, K. F., GAUL, S. L., SAARI, W. S., WAI, J. S. AND HOFFMAN, J. M.: Pyridinone derivatives: specific human immunodeficiency virus type 1 reverse transcriptase inhibitors with antiviral activity. Proc Natl. Acad. Sci. U.S.A. 88: 6863-6867, 1991.
14. GOODY, R. S., RITTINGER, K., DIVITA, G. AND GOODY, R. S.: Rational drug design and HIV: hopes and limitations. Human immunodeficiency virus reverse transcriptase substrate-induced conformational changes and the mechanism of inhibition by nonnucleoside inhibitors. Natl. Med. 1: 519-520, 1995.
15. HIZI, A., TAL, R., SHAHARABANY, M., CURRENS, M. J., BOYD, M. R., HUGHES, S. H. AND MCMAHON, J. B.: Specific inhibition of the reverse transcriptase of human immunodeficiency virus type 1 and the chimeric enzymes of human immunodeficiency virus type 1 and type 2 by nonnucleoside inhibitors. Antimicrob. Agents Chemother. 37: 1037-1042, 1993.
16. IM, G. J., TRAMONTANO, E., GONZALEZ, C. J. AND CHENG, Y. C.: Identification of the amino acid in the human immunodeficiency virus type 1 reverse transcriptase involved in the pyrophosphate binding of antiviral nucleoside triphosphate analogs and phosphonoformate. Implications for multiple drug resistance. Biochem. Pharmacol. 46: 2307-2313, 1993.
17. KASHMAN, Y., GUSTAFSON, K. R., FULLER, R. W., CARDELLINA, J., MCMAHON, J. B., CURRENS, M. J., BUCKHEIT, RWJ, HUGHES, S. H., CRAGG, G. M. AND BOYD, M. R.: The calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, Calophyllum lanigerum [published erratum appears in J. Med. Chem. 1993 Apr. 16: 36:1110]. J. Med. Chem. 35: 2735-2743, 1992.
18. MELLORS, J. W., DUTSCHMAN, G. E., IM, G. J., TRAMONTANO, E., WINKLER, S. R. AND CHENG, Y. C.: In vitro selection and molecular characterization of human immunodeficiency virus-1 resistant to non-nucleoside inhibitors of reverse transcriptase [published erratum appears in Mol. Pharmacol. 1992 Jul 42: 174]. Mol. Pharmacol. 41: 446-51, 1992.
19. NUNBERG, J. H., SCHLEIF, W. A., BOOTS, E. J., O'BRIEN, J. A., QUINTERO, J. C., HOFFMAN, J. M., EMINI, E. A. AND GOLDMAN, M. E.: Viral resistance to human immunodeficiency virus type 1-specific pyridinone reverse transcriptase inhibitors. J. Virol. 65: 4887-4892, 1991.
20. RICHMAN, D., SHIH, C. K., LOWY, I., ROSE, J., PRODANOVICH, P., GOFF, S. AND GRIFFIN, J: Human immunodeficiency virus type 1 mutants resistant to nonnucleoside inhibitors of reverse transcriptase arise in tissue culture. Proc. Natl. Acad. Sci. U.S.A. 88: 11241-11245, 1991.
21. SEGEL, I. H.: Multiple inhibition analysis-inhibition by mixtures of different inhibitors. In: Enzyme Kinetics. Behavior and Analysis of Rapid Equilibrium and Steady State Enzyme Systems, pp. 474-504, John Wiley and Sons, New York, 1975a
22. SEGEL, I. H.: Multiple inhibition analysis-multiple sites for a given inhibitor. In: Enzyme Kinetics. Behavior and Analysis of Rapid Equilibrium and Steady State Enzyme Systems, pp. 465-473, John Wiley and Sons, New York, 1975b.
23. ST. CLAIR, M. H., RICHARDS, C. A., SPECTOR, T., WEINHOLD, K. J., MILLER, W. H., LANGLOIS, A. J. AND FURMAN, P. A.: 3′-Azido-3′-deoxythymidine triphosphate as an inhibitor and substrate of purified human immunodeficiency virus reverse transcriptase. Antimicrob. Agents Chemother. 31: 1972-1977, 1987.
24. TAYLOR, P. B., CULP, J. S., DEBOUCK, C., JOHNSON, R. K., PATIL, A. D., WOOLF, D. J., BROOKS, I. AND HERTZBERG, R. P.: Kinetic and mutational analysis of human immunodeficiency virus type 1 reverse transcriptase inhibition by inophyllums, a novel class of non-nucleoside inhibitors. J. Biol. Chem. 269: 6325-6331, 1994.
25. VRANG, L. AND OBERG, B: PPi analogs as inhibitors of human T-lymphotropic virus type III reverse transcriptase. Antimicrob. Agents Chemother. 29: 867-872, 1986.
26. WAINBERG, M. A., GAO, Q., YAO, X. J., PARNIAK, M. A., FANNING, M., MONTANER, J. S., O'SHAUGHNESSY, M., TSOUKAS, C. AND RUEDY, J: Rapid generation of AZT-resistant strains of HIV-1 after low-dose therapy and by in vitro selection. Int. Conf. AIDS 7: 79, 1991.
27. WHITE, E. L., SHADDIX, S. C., VINCE, R., SHANNON, W. M. AND PARKER, W. B.: Mechanism of inhibition by carbovir triphosphate of HIV reverse transcriptase and human DNA polymerases, compared with the action of AZT triphosphate and dideoxynucleoside triphosphates. Int. Conf. AIDS 6: 266, 1990.
28. YONETANI, T. AND THEORELL, H: Studies on liver alcohol dehydrogenase complexes III. Multiple inhibition kinetics in the presence of two competitive inhibitors. Arch. Biochem. Biophys. 106: 243-251, 1964.
29. BABA, M., DECLERCQ, E., TANAKA, H., UBASAWA, M., TAKASHIMA, H., SEKIYA, K., NITTA, I., UMEZU, K., NAKASHIMA, H. AND MORI, S: Potent and selective inhibition of human immunodeficiency virus type 1 (HIV-1) by 5-ethyl-6-phenylthiouracil derivatives through their interaction with the HIV-1 reverse transcriptase. Proc. Natl. Acad. Sci. U.S.A. 88: 2356-2360, 1991a.